2614 PUBLICATIONS
ANNÉE
JOURNAL
PREMIER AUTEUR
TITRE
ANNÉE2022
JOURNALClinics and research in hepatology and gastroenterology
PREMIER AUTEURNeuzillet C
TITRECorrelation between efficacy endpoints in patients with advanced biliary tract cancer treated by systemic second-line therapies: analysis of aggregated data from a systematic literature review.
ANNÉE2022
JOURNALThe oncologist
PREMIER AUTEURThouvenin J
TITREEfficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.
ANNÉE2022
JOURNALStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
PREMIER AUTEURRetif P
TITREEvaluation of the ability of the Brainlab Elements Cranial Distortion Correction algorithm to correct clinically relevant MRI distortions for cranial SRT.
ANNÉE2022
JOURNALCancer
PREMIER AUTEURColonna M
TITREHealth status of prevalent cancer cases as measured by mortality dynamics (cancer vs. noncancer): Application to five major cancers sites.
ANNÉE2022
JOURNALFrontiers in oncology
PREMIER AUTEURLanglois B
TITRELRP-1-dependent control of calpain expression and activity: A new mechanism regulating thyroid carcinoma cell adhesion.
ANNÉE2022
JOURNALCancers
PREMIER AUTEURLegrand T
TITREPreneoplastic Lesions in Surgical Specimens Do Not Worsen the Prognosis of Patients Who Underwent Surgery for Pancreatic Adenocarcinoma: Post-Hoc Analysis of the PRODIGE 24-CCTG PA 6 Trial.
ANNÉE2022
JOURNALThe Lancet. Oncology
PREMIER AUTEURWesteel V
TITREChest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.
ANNÉE2022
JOURNALEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
PREMIER AUTEURPâris P
TITREDiffusion-weighted and gadolinium-enhanced dynamic MRI in parotid gland tumors.
ANNÉE2022
JOURNALActa oncologica (Stockholm, Sweden)
PREMIER AUTEURHennemann A
TITREEfficacy of pembrolizumab in a patient with xeroderma pigmentosum variant and advanced cutaneous squamous-cell carcinoma.
ANNÉE2022
JOURNALFrontiers in oncology
PREMIER AUTEURLang H
TITREIntegrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies.

Retrouvez aussi

Personnes
Equipes
Plateformes
Unités de recherche, établissements
Projets de recherche
Publications scientifiques